Cargando…

Decisions about adopting novel COVID‐19 vaccines among White adults in a rural state, USA: A qualitative study

PURPOSE: Many people, especially in rural areas of the United States, choose not to receive novel COVID‐19 vaccinations despite public health recommendations. Understanding how people describe decisions to get vaccinated or not may help to address hesitancy. METHODS: We conducted semistructured inte...

Descripción completa

Detalles Bibliográficos
Autores principales: Kohut, Mike, Scharnetzki, Liz, Pajka, Joseph, Jacobs, Elizabeth A., Fairfield, Kathleen M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154856/
https://www.ncbi.nlm.nih.gov/pubmed/36864735
http://dx.doi.org/10.1111/hex.13714
_version_ 1785036213753741312
author Kohut, Mike
Scharnetzki, Liz
Pajka, Joseph
Jacobs, Elizabeth A.
Fairfield, Kathleen M.
author_facet Kohut, Mike
Scharnetzki, Liz
Pajka, Joseph
Jacobs, Elizabeth A.
Fairfield, Kathleen M.
author_sort Kohut, Mike
collection PubMed
description PURPOSE: Many people, especially in rural areas of the United States, choose not to receive novel COVID‐19 vaccinations despite public health recommendations. Understanding how people describe decisions to get vaccinated or not may help to address hesitancy. METHODS: We conducted semistructured interviews with 17 rural inhabitants of Maine, a sparsely populated state in the northeastern US, about COVID‐19 vaccine decisions during the early rollout (March–May 2021). We used the framework method to compare responses, including between vaccine Adopters and Non‐adopters. FINDINGS: Adopters framed COVID‐19 as unequivocally dangerous, if not personally, then to other people. Describing their COVID concerns, Adopters emphasized disease morbidities. By contrast, Non‐adopters never mentioned morbidities, referencing instead mortality risk, which they perceived as minimal. Instead of risks associated with the disease, Non‐adopters emphasized risks associated with vaccination. Uncertainty about the vaccine development process, augmented by social media, bolstered concerns about the long‐term unknown risks of vaccines. Vaccine Adopters ultimately described trusting the process, while Non‐adopters expressed distrust. CONCLUSION: Many respondents framed their COVID vaccination decision by comparing the risks between the disease and the vaccine. Associating morbidity risks with COVID‐19 diminishes the relevance of vaccine risks, whereas focusing on low perceived mortality risks heightens their relevance. Results could inform efforts to address COVID‐19 vaccine hesitancy in the rural US and elsewhere. PATIENT OR PUBLIC CONTRIBUTION: Members of Maine rural communities were involved throughout the study. Leaders of community health groups provided feedback on the study design, were actively involved in recruitment, and reviewed findings after analysis. All data produced and used in this study were co‐constructed through the participation of community members with lived experience.
format Online
Article
Text
id pubmed-10154856
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-101548562023-05-04 Decisions about adopting novel COVID‐19 vaccines among White adults in a rural state, USA: A qualitative study Kohut, Mike Scharnetzki, Liz Pajka, Joseph Jacobs, Elizabeth A. Fairfield, Kathleen M. Health Expect Original Articles PURPOSE: Many people, especially in rural areas of the United States, choose not to receive novel COVID‐19 vaccinations despite public health recommendations. Understanding how people describe decisions to get vaccinated or not may help to address hesitancy. METHODS: We conducted semistructured interviews with 17 rural inhabitants of Maine, a sparsely populated state in the northeastern US, about COVID‐19 vaccine decisions during the early rollout (March–May 2021). We used the framework method to compare responses, including between vaccine Adopters and Non‐adopters. FINDINGS: Adopters framed COVID‐19 as unequivocally dangerous, if not personally, then to other people. Describing their COVID concerns, Adopters emphasized disease morbidities. By contrast, Non‐adopters never mentioned morbidities, referencing instead mortality risk, which they perceived as minimal. Instead of risks associated with the disease, Non‐adopters emphasized risks associated with vaccination. Uncertainty about the vaccine development process, augmented by social media, bolstered concerns about the long‐term unknown risks of vaccines. Vaccine Adopters ultimately described trusting the process, while Non‐adopters expressed distrust. CONCLUSION: Many respondents framed their COVID vaccination decision by comparing the risks between the disease and the vaccine. Associating morbidity risks with COVID‐19 diminishes the relevance of vaccine risks, whereas focusing on low perceived mortality risks heightens their relevance. Results could inform efforts to address COVID‐19 vaccine hesitancy in the rural US and elsewhere. PATIENT OR PUBLIC CONTRIBUTION: Members of Maine rural communities were involved throughout the study. Leaders of community health groups provided feedback on the study design, were actively involved in recruitment, and reviewed findings after analysis. All data produced and used in this study were co‐constructed through the participation of community members with lived experience. John Wiley and Sons Inc. 2023-03-02 /pmc/articles/PMC10154856/ /pubmed/36864735 http://dx.doi.org/10.1111/hex.13714 Text en © 2023 The Authors. Health Expectations published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Kohut, Mike
Scharnetzki, Liz
Pajka, Joseph
Jacobs, Elizabeth A.
Fairfield, Kathleen M.
Decisions about adopting novel COVID‐19 vaccines among White adults in a rural state, USA: A qualitative study
title Decisions about adopting novel COVID‐19 vaccines among White adults in a rural state, USA: A qualitative study
title_full Decisions about adopting novel COVID‐19 vaccines among White adults in a rural state, USA: A qualitative study
title_fullStr Decisions about adopting novel COVID‐19 vaccines among White adults in a rural state, USA: A qualitative study
title_full_unstemmed Decisions about adopting novel COVID‐19 vaccines among White adults in a rural state, USA: A qualitative study
title_short Decisions about adopting novel COVID‐19 vaccines among White adults in a rural state, USA: A qualitative study
title_sort decisions about adopting novel covid‐19 vaccines among white adults in a rural state, usa: a qualitative study
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154856/
https://www.ncbi.nlm.nih.gov/pubmed/36864735
http://dx.doi.org/10.1111/hex.13714
work_keys_str_mv AT kohutmike decisionsaboutadoptingnovelcovid19vaccinesamongwhiteadultsinaruralstateusaaqualitativestudy
AT scharnetzkiliz decisionsaboutadoptingnovelcovid19vaccinesamongwhiteadultsinaruralstateusaaqualitativestudy
AT pajkajoseph decisionsaboutadoptingnovelcovid19vaccinesamongwhiteadultsinaruralstateusaaqualitativestudy
AT jacobselizabetha decisionsaboutadoptingnovelcovid19vaccinesamongwhiteadultsinaruralstateusaaqualitativestudy
AT fairfieldkathleenm decisionsaboutadoptingnovelcovid19vaccinesamongwhiteadultsinaruralstateusaaqualitativestudy